Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.
Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter D
| Generic Name | Trade Name | Condition | Study Code | Study Name | Access to study | Access to results |
|---|---|---|---|---|---|---|
| DOCETAXEL | Taxotere | Prostate Cancer, Hormone Refractory | ARD6562 (XRP6976J/2101) | NA | NCT00291005 | |
| DOCETAXEL | Taxotere | Cancer, Prostate, Hormone Refractory | ARD6563 (XRP6976J/2102) | NA | NCT00723086 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | DOCET_L_00712 | NA | NCT00364611 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | DOCET_L_00713 | NA | NCT00446030 | |
| DOCETAXEL | Taxotere | Non Small Cell Lung Cancer | DOCET_L_00714 | NA | NCT00365365 | |
| DOCETAXEL | Taxotere | Non Small Cell Lung Cancer | DOCET_L_00730 | NA | NCT00378573 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms, Breast Neoplasms | DOCET_L_02195 | NA | NCT00811447 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms, Breast Neoplasms | DOCET_L_04203 | MOTIF | NCT00917748 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | DOCET_L_04827 | TFINE | NCT01038661 | |
| DOCETAXEL | Taxotere | Esophageal Neoplasms | DOCET_R_03761 | NA | NCT00816543 | |
| DOCETAXEL | Taxotere | Stomach Neoplasms | DOCOX_C_00082 | NA | NCT00382720 | |
| DOCETAXEL | Taxotere | Non Small Cell Lung Cancer | DOCOX_L_00716 | NA | NCT00356122 | |
| DOCETAXEL | Taxotere | Nasopharyngeal Neoplasms | EFC10339 | NA | NCT00565448 | |
| DOCETAXEL | Taxotere | Cancer, Head and Neck | EFC6041 | TAX316 | NCT00688740 | |
| DOCETAXEL | Taxotere | Cancer, Head and Neck | EFC6043 | NA | NCT00273546 | |
| DOCETAXEL | Taxotere | Cancer, Head and Neck | EFC6044 | NA | NCT00290966 | |
| DOCETAXEL | Taxotere | Cancer, Head and Neck | EFC6051 (XRP6976G/322) | NA | NCT00401323 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | RP56976_PR_315 | BIG 02/98 | NCT00174655 | |
| DOCETAXEL | Taxotere | Squamous Cell Carcinoma | TAX_AT1_203 | NA | NCT00432315 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | TAX_ES1_209 | NA | NCT00258739 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | TAX_ES1_302 | NA | NCT00174629 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | TAX_FR1_236 | NA | NCT00521521 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | TAX_GMA_301 | NA | NCT00312208 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | TAX_IT1_302 | NA | NCT00174707 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | XRP6976A_2504 | RETAX | NCT00620100 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | XRP6976B_2501 | NA | NCT00425191 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | XRP6976B_2503 | NA | NCT00263016 | |
| DOCETAXEL | Taxotere | Cancer, Non-Small-Cell Lung | XRP6976B_2505 | PULMONART | NCT00174772 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | XRP6976B_2506 | ADVANCED | EudraCT: 2004-001044-72 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | XRP6976B_2507 | NA | NCT00271323 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | XRP6976B_6020 | CARBO-TAX | NCT00826852 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | XRP6976D_2502 | GETNA 2 | NCT00617968 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | XRP6976D_2504 | NA | NCT00461344 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | XRP6976D-311 | NA | NCT00002662 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976F_2501 | NA | NCT00357149 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976F_2502 | NA | NCT00916097 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976F_3501 | NA | NCT00539630 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976F_6002 | NA | NCT00436293 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976F_6007 | TAX-NAZO | NCT00772681 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976G_2501 | NA | NCT00268671 | |
| DOCETAXEL | Taxotere | Ovarian Neoplasms | XRP6976I_2502 | NA | NCT00539669 | |
| DOCETAXEL | Taxotere | Ovarian Neoplasms | XRP6976I_6012 | TAX-OVER | NCT00772863 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_2501 | NA | NCT00069888 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_2503 | NA | NCT00268710 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_2504 | NA | NCT00494338 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_3501 | NA | NCT00283062 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_3502 | PROSTATA | EudraCT: 2004-003885-14 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_3503 | NA | NCT00514917 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | XRP6976J_4001 | NA | EudraCT: 2005-001873-91 | |
| DOCETAXEL | Taxotere | Stomach Neoplasms | DOCET_L_00072 | NEO-TAX | NCT00343239 | |
| DOCETAXEL | Taxotere | Prostatic Neoplasms | DOCET_L_01833 | NA | NCT00436839 | |
| DOCETAXEL | Taxotere | Neoplasms | DOCET_L_04775 | GRANOTAX | NCT01107756 | |
| DOCETAXEL | Taxotere | Lung Neoplasms | DOCET_L_05158 | C-CRISP | NCT01266512 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | XRP6976F_2503 | NA | NCT00261703 | |
| DOCETAXEL | Taxotere | Breast Neoplasms | TAX_GMA_302 | NA | EudraCT:2008-005127-29 | |
| DOCETAXEL | Taxotere | Squamous Cell Carcinoma | DOCETL06445 | NA | NCT02061631 | |
| DOCETAXEL | Taxotere | Head and Neck neoplasms | DOCET_L_02557 | NA | NCT00995293 | |
| DOXERCALCIFEROL | Hectorol | Osteoporosis | BCI-CH-102* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-106* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-108-LA* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-108-Memphis* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-110* | NA | ||
| DOXERCALCIFEROL | Hectorol | Secondary Hyperparathyroidism | BCI-CH-112* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-114-Memphis* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-115* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-119* | NA | ||
| DOXERCALCIFEROL | Hectorol | Elevated Parathyroid Hormone Levels | BCI-CH-120* | NA | ||
| DOXERCALCIFEROL | Hectorol | Prostate Cancer | BCI-CH-125* | NA | ||
| DOXERCALCIFEROL | Hectorol | Seondary Hyperparathyroidism | BCI-CH-126* | NA | ||
| DOXERCALCIFEROL | Hectorol | Seondary Hyperparathyroidism | BCI-CH-144* | NA | ||
| DOXERCALCIFEROL | Hectorol | Seondary Hyperparathyroidism | BCI-CH-147* | NA | ||
| DOXERCALCIFEROL | Hectorol | Psoriasis | HECTPS02507 | NA | NCT00601107 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRI10939 | NA | NCT01213368 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRONE_L_05066 | AFRODITE | EudraCT: 2009-018215-53 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | EFC4968 | DIONYSOS | NCT00489736 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | EFC5555 | ATHENA | NCT00174785 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | EFC11405 | PALLAS | NCT01151137 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRONE_L_04742 | ELECTRA | NCT01026090 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRONE_L_04315 | ODYSSEUS | NCT01198873 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRONE_L_04316 | HESTIA | NCT01135017 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRONE_L_03668 | ARTEMIS Load | EudraCT: 2009-016818-24 | |
| DRONEDARONE | Multaq | Atrial Fibrillation | DRONE_L_04629 | ARTEMIS Long Term | EudraCT: 2010-019247-19 | |
| DROTAVERINE | No-Spa | Menstruation Disturbances | L_8752 | DOROTA | NA | |
| DROTAVERINE | No-Spa | Menstruation Disturbances | L_9134 | NA | EudraCT: 2004-003809-25 | |
| DUPILUMAB | Not marketed | Nasal polyps | ACT12340 | NA | EudraCT: 2013-001803-35 | |
| DUPILUMAB | Not marketed | Asthma | ACT11457 | NA | NCT01312961 | |
| DUPILUMAB | Not marketed | Asthma | DRI12544 | NA | EudraCT: 2013-000856-16 | |
| DUPILUMAB | Not marketed | Asthma | EFC13579 | LIBERTY ASTHMA QUEST | EudraCT: 2014-004940-36 | |
| DUPILUMAB | Not marketed | Asthma | EFC13691 | LIBERTY ASTHMA VENTURE | EudraCT: 2015-001573-40 | |
| DUPILUMAB | Not marketed | Asthma | PDY14192 | LIBERTY ASTHMA VENTURE | EudraCT: 2015-001572-22 |
References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted